Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cibus Inc (NQ: CBUS )

9.650 +0.200 (+2.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 132,146
Open 9.500
Bid (Size) 9.410 (1)
Ask (Size) 10.00 (1)
Prev. Close 9.450
Today's Range 9.500 - 10.11
52wk Range 8.900 - 24.61
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
From Cibus US LLC
Via GlobeNewswire
Cibus Announces $13.0 Million Registered Direct Offering
From Cibus US LLC
Via GlobeNewswire

Performance

YTD
-47.44%
-47.44%
1 Month
-40.10%
-40.10%
3 Month
-48.34%
-48.34%
6 Month
-43.83%
-43.83%
1 Year
-39.16%
-39.16%

More News

Read More
CIBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cibus, Inc. on Behalf of Cibus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Cibus to Participate in Upcoming June Investor Events
From Cibus US LLC
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
From Cibus US LLC
Via GlobeNewswire
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in the BMO Global Farm to Market Conference
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Cibus Reports First Quarter Financial Results and Provides Business Update
From Cibus US LLC
Via GlobeNewswire
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
From Cibus US LLC
Via GlobeNewswire
Earnings Scheduled For March 21, 2024
Via Benzinga
Cibus Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in the 36th Annual Roth Conference
From Cibus US LLC
Via GlobeNewswire
Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US
From Cibus US LLC
Via GlobeNewswire
European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques
From Cibus US LLC
Via GlobeNewswire
European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques
From Cibus US LLC
Via GlobeNewswire
Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales
From Cibus US LLC
Via GlobeNewswire
Cibus Announces Major Breakthrough in Wheat Regeneration from Single Cells
From Cibus US LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.